A year-long randomized trial found that a structured, online team-based care model delivered quality-of-life and disease severity improvements equivalent to in-person visits for atopic dermatitis patients. The virtual model also cut initial evaluation time by about 14 minutes. Researchers say the findings support telehealth as a high-quality option for managing chronic skin conditions.
A 12-month randomized equivalence trial of 300 children and adults with atopic dermatitis (AD) found that an online, team-based connected health (TCH) model delivered improvements in disease severity and quality of life that were statistically equivalent to conventional in-person care. In the TCH model, patients submitted clinical histories and skin photos asynchronously to dermatologists, who coordinated with primary care physicians to provide diagnoses, treatment plans, and follow-up — all through a secure online platform.
Across every primary and secondary outcome — including EASI, IGA, POEM, and quality-of-life scores — differences between the online and in-person groups fell well within prespecified equivalence margins. Adverse event rates were also comparable between groups. Notably, the online group required far fewer dermatologist visits (0.07 vs. 2.40 per participant), and the initial evaluation was significantly faster.
By the Numbers:
Why it matters: With millions of AD patients facing barriers like long wait times and transportation challenges, this trial offers rigorous evidence that structured telehealth can deliver care quality on par with in-person visits — potentially reshaping how chronic dermatologic conditions are managed at scale.
